<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">AID</journal-id><journal-title-group><journal-title>Advances in Infectious Diseases</journal-title></journal-title-group><issn pub-type="epub">2164-2648</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/aid.2014.44024</article-id><article-id pub-id-type="publisher-id">AID-51359</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  First Evidence of Hantavirus in Central Iran as an Emerging Viral Disease
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>adegh</surname><given-names>Chinikar</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Abbas</surname><given-names>Ali Javadi</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Arash</surname><given-names>Hajiannia</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Behroz</surname><given-names>Ataei</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Tahmineh</surname><given-names>Jalali</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sahar</surname><given-names>Khakifirouz</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Norbert</surname><given-names>Nowotny</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jonas</surname><given-names>Schmidt-Chanasit</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Nariman</surname><given-names>Shahhosseini</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>Institute of Virology, University of Veterinary Medicine, Vienna, Austria</addr-line></aff><aff id="aff4"><addr-line>WHO Collaborating Centre for Arbovirus and Haemorrhagic Fever Reference and Research, Department of 
Virology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany</addr-line></aff><aff id="aff2"><addr-line>Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran</addr-line></aff><aff id="aff1"><addr-line>Arboviruses and Viral Haemorrhagic Fevers Laboratory (National Ref. Lab), Department of Virology, Pasteur Institute of Iran, Tehran, Iran</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>behrouzataei@chmail.ir(AC)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>13</day><month>11</month><year>2014</year></pub-date><volume>04</volume><issue>04</issue><fpage>173</fpage><lpage>177</lpage><history><date date-type="received"><day>21</day>	<month>July</month>	<year>2014</year></date><date date-type="rev-recd"><day>21</day>	<month>August</month>	<year>2014</year>	</date><date date-type="accepted"><day>18</day>	<month>September</month>	<year>2014</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
   Hantavirus is a zoonosis transmitted from rodents to humans. Asymptomatic infected rodents can secrete hantaviruses in the urine, feces, and saliva. The main route of infection transmission to human is aerosols contaminated with the virus. This study was designed to evaluate the serological and molecular prevalence of hantavirus as an emerging zoonoses disease among street sweepers in Isfahan province, central Iran. Serum samples from 200 street sweepers in healthy condition and those with recent renal failure were tested by ELISA (IgM and IgG). Molecular analysis was subsequently applied for IgM positive cases. From these samples, 9 (4.5%) were positive, of which 2 (22.22%) were positive for both IgM and RT-PCR, while 7 (77.77%) were positive for IgG. The mean age and work experience of the positive cases were 39.7 and 11.5 respectively. According to our observations, all positive cases reported prevalence of rodents in their work place. The logistic regression test showed that the age and work experience were not risk factors for being positive, but prevalence of rodents in work place was a risk factor for being positive, when compared with negative cases. This is the first comprehensive study on the prevalence of hantavirus with positive results coming from Iranian population, which can raise the public awareness for the hantavirus infections as a public health threat. 
 
</p></abstract><kwd-group><kwd>Hantavirus</kwd><kwd> Emergence Zoonoses</kwd><kwd> Rodent</kwd><kwd> Arboviruses</kwd><kwd> Iran</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>0B1. Introduction</title><p>Hantaviruses are members of the genus Hantavirus of the family Bunyaviridae. Hantaviruses are enveloped, single-stranded, negative-sensed and tri-segmented RNA viruses. In contrast to the other members of the family, arthropod vectors, hantaviruses generally chronically infect rodents. Hantaviruses have co-evolved with their rodent hosts through millions of years and each hantavirus has its own specific rodent host species [<xref ref-type="bibr" rid="scirp.51359-ref1">1</xref>] .</p><p>Human infection with hantaviruses have been associated with two main diseases. The diseases in the Old World called Hemorrhagic Fever with Renal Syndrome (HFRS) with annual estimate of 150,000 to 200,000 occurrence are caused by Myodes-, Rattus-, and Apodemus-borne hantaviruses [<xref ref-type="bibr" rid="scirp.51359-ref1">1</xref>] . HFRS cases mainly have been reported from China (with more than half of global cases), Russia, Korea, Japan, Finland, Sweden, Bulgaria, Greece, Hungary, France, and the Balkan countries [<xref ref-type="bibr" rid="scirp.51359-ref2">2</xref>] . Clinical presentation of HFRS consists of sudden fever, severe lumbalgia, acute renal failure (ARF) and particular thrombocytopenia. Moreover, it should be noted that the majority of human hantavirus infections have no vivid clinical symptoms and may appear to be uncharacteristic. This property makes the diagnosis of hantavirus infections difficult, especially in regions where the disease is not endemic [<xref ref-type="bibr" rid="scirp.51359-ref3">3</xref>] . Death rates range from less than 0.1% for HFRS caused by Puumala virus to approximately 5% to 10% for HFRS caused by Hantaan virus. Most patients with HFRS recover completely, but sever complications may develop [<xref ref-type="bibr" rid="scirp.51359-ref4">4</xref>] .</p><p>The disease in the New World called Hantavirus Pulmonary Syndrome (HPS) or hantavirus cardiopulmonary syndrome (HCPS) is caused by the sigmodontine-borne hantaviruses [<xref ref-type="bibr" rid="scirp.51359-ref5">5</xref>] . HPS occurs mainly in the USA and Canada and has a death rate of 40% and/or 60% in some outbreaks. In spite of disparity in geographical distribution and illnesses, the Old World and New World hantaviruses have similarities in the organizations of their nucleic sequences and their life cycles [<xref ref-type="bibr" rid="scirp.51359-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.51359-ref6">6</xref>] .</p><p>Till now, over 21 hantaviruses have been detected. Several hantaviruses may remain undiscovered, since in many countries, hantaviral infections are likely to go undetected and not reported, especially in Africa, the Middle East, and the Indian subcontinent [<xref ref-type="bibr" rid="scirp.51359-ref5">5</xref>] .</p><p>Hantavirus is a zoonosis transmitted from rodents to humans. Asymptomatic infected rodents can secrete hantaviruses in the urine, feces, and saliva. The main route of infection transmission to human, as incidental hosts, is aerosols contaminated with the virus. Also, bites by infected rodents or exposure to broken skin or mucous membranes may represent alternative routes. Although specific risk factors are poorly defined, persons of lower socioeconomic status, who are engaging in activities that bring them in closer contact with rodents and/or their excretions may be at a higher risk for infection [<xref ref-type="bibr" rid="scirp.51359-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.51359-ref8">8</xref>] .</p><p>Epidemiological investigations have shown that farmers, soldiers, and rural inhabitants are high-risk groups for hantavirus. Initially, it was believed that hantavirus occurred only in rural areas, but careful consideration showed that some hantavirus infections could also happen in urbanized cities and in many parts of the world [<xref ref-type="bibr" rid="scirp.51359-ref5">5</xref>] .</p><p>From 2008 to 2009, to find the first evidence of hantavirus in Iran, 10 serum samples of patients with acute renal failure and thrombocytopenia with no obvious causative reason were collected from nephrology and dialysis unit of Imam Hossein Hospital in Tehran, capital of Iran. All samples were analyzed for antibodies against hantavirus by Immunofluorescent assay (IFA), but no seropositive cases were found.</p><p>As the epidemiology of hantavirus in Iran is not clear, this study was designed to evaluate the prevalence of hantavirus in human cases in Isfahan province, central Iran. In this regard, street sweepers were selected as the study group, because of their high inhalation probability of contaminated aerosols with rodents’ feces as the main reservoirs of hantavirus.</p></sec><sec id="s2"><title>1B2. Methods</title><sec id="s2_1"><title>8B2.1. Sampling</title><p>200 serum samples from central Iran were collected from street sweeper man with acute renal failure, fever and thrombocytopenia in early-phase serum specimens and those in healthy conditions, both groups with possible exposure to rodents in March 2013. After completion of questionnaires, their specimens were submitted to Arboviruses and Viral Haemorrhagic Fevers Laboratory (National Reference Laboratory) of the Pasteur Institute of Iran. This laboratory is responsible for surveillance, rapid diagnosis and awareness of VHFs, including Crimean- Congo Hemorrhagic Fever Virus [<xref ref-type="bibr" rid="scirp.51359-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.51359-ref10">10</xref>] , Dengue virus [<xref ref-type="bibr" rid="scirp.51359-ref11">11</xref>] , West Nile virus [<xref ref-type="bibr" rid="scirp.51359-ref12">12</xref>] , Rift Valley Fever virus [<xref ref-type="bibr" rid="scirp.51359-ref13">13</xref>] and Hanta virus in Iran.</p></sec><sec id="s2_2"><title>9B2.2. Serological Assay</title><p>The most common tools for the laboratory diagnosis of hantavirus infections are serological tests, which detect IgM and/or IgG antibodies against hantaviral antigens in serum. By far indirect IgG and IgM Enzyme-linked Immunosorbent Assays (ELISAs) as well as IgM capture ELISAs are the most reliable and routine serological assay for hantaviruses.</p><p>IgM: Serum samples were diluted (1/100) by adding 1 &#181;l serum samples to 100 &#181;l of sample dilution. Subsequently, 100 &#181;l of the 1/100 dilutions of serum samples, 100 &#181;l of positive control, 100 &#181;l of cut off and 100 &#181;l of negative control were added into the corresponding wells and incubated at 37˚C for 60 min. The following steps were undertaken according to the manufacturer’s instructions of the Anti-Hanta Virus Pool ELISA IgM kit (Cat no. El 278h-9601-1 M, EUROIMMUN) [<xref ref-type="bibr" rid="scirp.51359-ref14">14</xref>] - [<xref ref-type="bibr" rid="scirp.51359-ref16">16</xref>] .</p><p>IgG: 100 &#181;l of the 1/100 dilutions of serum samples, 100 &#181;l of positive control, 100 &#181;l of cut off and 100 &#181;l of negative control were added into the corresponding wells and incubated at 37˚C for 60 min. The subsequent steps were undertaken according to the manufacturer’s instruction of the Anti-Hanta Virus Pool ELISA IgG kit (Cat no. El 278h-9601-1 G, EUROIMMUN) [<xref ref-type="bibr" rid="scirp.51359-ref14">14</xref>] - [<xref ref-type="bibr" rid="scirp.51359-ref16">16</xref>] .</p></sec><sec id="s2_3"><title>10B2.3. Molecular Assay</title><p>Performing RT-PCR on acute phase serum specimens during the first 10 days of illness can be positive. All the samples found IgM positive by ELISA were further tested by RT-PCR. For this purpose, viral RNA was extracted from 140 μl of serum samples using a QIAamp RNA kit according to the instructions of the manufacturer (Cat No. 52906, Qiagen GmbH, Hilden, Germany). Extracted RNA was stored at −80&#176;C. Then, extracted RNA was analyzed by one-step RT-PCR using the following primers for S segment of virus genome: KPS1 (3’-ATTG ATGAACCTACCAGGACAGACAGC-5’) and KPS2 (3’-ATAAACAAGCATGTTGGTGGACA-5’), and the following primers for M segment: HS1 (3’-ACCTGTCAATTTGGTGACCC-5’) and HS2 (3’-TCACAAGCCTT TATTGATGT-5’) [<xref ref-type="bibr" rid="scirp.51359-ref17">17</xref>] .</p></sec><sec id="s2_4"><title>11B2.4. Statistical Analysis</title><p>Data analysis was performed by SPSS (version 16, SPSS Inc, Chicago) software package. Descriptive statistics (i.e. frequencies and percentages) were used to summarize the quantitative variables. To evaluate the risk factors for being positive, the logistic regression test was used. P-values &lt; 0.05 were considered significant.</p></sec></sec><sec id="s3"><title>2B3. Results</title><p>In this study, serum samples from 200 cases, all from Isfahan province in central Iran, were tested. From these samples, 9 (4.5%) were positive, of which 2 (22.22%) were positive for both IgM and RT-PCR among acute renal failure patients, while 7 (77.77%) were positive for IgG among healthy participants. The mean age and work experience of the positive cases were 39.7 and 11.5 respectively (<xref ref-type="table" rid="table1">Table 1</xref>).</p><p>Among the positive cases, 4 (44.44%) cases reported high prevalence of rodent in work place, 3 (33.33%) cases reported middle prevalence of rodent in work place and 2 (22.22%) reported low prevalence of rodent prevalence in work place. All cases are survived.</p><p>The logistic regression test showed that the age and work experience were not risk factor for being positive, but prevalence of rodents in work place was a risk factor for being positive, when compared with negative cases.</p></sec><sec id="s4"><title>3B4. Discussion</title><p>Hantaviruses are emerging viruses that cause hemorrhagic fever with renal syndrome (HFRS) in Asia and Eu- rope and hantavirus cardiopulmonary syndrome in North and South America. The global distribution of rodents,</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Summary of patients with positive hantavirus in central Iran</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >No.</th><th align="center" valign="middle" >Age</th><th align="center" valign="middle" >Work Experience</th><th align="center" valign="middle" >Prevalence of Rodent in Work Place</th><th align="center" valign="middle" >IgM</th><th align="center" valign="middle" >IgG</th><th align="center" valign="middle" >RT-PCR</th></tr></thead><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >31</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >Middle</td><td align="center" valign="middle" >Neg</td><td align="center" valign="middle" >Pos</td><td align="center" valign="middle" >Neg</td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >46</td><td align="center" valign="middle" >22</td><td align="center" valign="middle" >High</td><td align="center" valign="middle" >Neg</td><td align="center" valign="middle" >Pos</td><td align="center" valign="middle" >Neg</td></tr><tr><td align="center" valign="middle" >3</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >Low</td><td align="center" valign="middle" >Neg</td><td align="center" valign="middle" >Pos</td><td align="center" valign="middle" >Neg</td></tr><tr><td align="center" valign="middle" >4</td><td align="center" valign="middle" >39</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >Low</td><td align="center" valign="middle" >Pos</td><td align="center" valign="middle" >Neg</td><td align="center" valign="middle" >Pos</td></tr><tr><td align="center" valign="middle" >5</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >High</td><td align="center" valign="middle" >Neg</td><td align="center" valign="middle" >Pos</td><td align="center" valign="middle" >Neg</td></tr><tr><td align="center" valign="middle" >6</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >22</td><td align="center" valign="middle" >Middle</td><td align="center" valign="middle" >Pos</td><td align="center" valign="middle" >Neg</td><td align="center" valign="middle" >Pos</td></tr><tr><td align="center" valign="middle" >7</td><td align="center" valign="middle" >51</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >Middle</td><td align="center" valign="middle" >Neg</td><td align="center" valign="middle" >Pos</td><td align="center" valign="middle" >Neg</td></tr><tr><td align="center" valign="middle" >8</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >High</td><td align="center" valign="middle" >Neg</td><td align="center" valign="middle" >Pos</td><td align="center" valign="middle" >Neg</td></tr><tr><td align="center" valign="middle" >9</td><td align="center" valign="middle" >46</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >High</td><td align="center" valign="middle" >Neg</td><td align="center" valign="middle" >Pos</td><td align="center" valign="middle" >Neg</td></tr></tbody></table></table-wrap><p>the main reservoirs of hantaviruses, provides great disease-causing potential. Hantavirus infection is a grave public health concern in Asia, Europe, and the Americas wherever rodents of the family Muridae are present, and they have been identified in rodents of the subfamilies Murinae, Arvicolinae, and Sigmodontinae [<xref ref-type="bibr" rid="scirp.51359-ref18">18</xref>] .</p><p>Previous studies demonstrated that the aerosol route of infection is undoubtedly the most common mean of transmission among rodents and to humans. Epidemiologic studies have linked virus exposure to activities like farm work, threshing, sleeping on the ground, and military exercises. Also, indoor exposure may happen when field rodents attack or settle in a home during cold weather. Hantavirus infection is mainly seen in persons of lower socioeconomic status because poorer housing conditions and farming activities favor closer contact between humans and rodents [<xref ref-type="bibr" rid="scirp.51359-ref2">2</xref>] .</p><p>In the neighbouring countries of Iran, It seems that the most cases have been reported from Turkey [<xref ref-type="bibr" rid="scirp.51359-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.51359-ref19">19</xref>] . As part of our ongoing surveillance on viral zoonoses in Iran, human sera from street sweepers were collected in Isfahan province. This is the first comprehensive study on the prevalence of hantavirus infection coming from Iranian population. The prevalence of antibodies to hantavirus among the 200 human sera was 4.5%.</p><p>The report of two molecular positive cases in this study should alert physicians that hantavirus infection should be noticed in the differential diagnosis of patients who have high fever and thrombocytopenia with negative laboratory results for other endemic viral hemorrhagic fevers like Crimean-Congo hemorrhagic fever in Iran.</p><p>According to our observations, all positive cases reported prevalence of rodent in their work place. Although two patients declared low rodent prevalence in their work place, this infection route cannot be excluded as street sweepers spent most of their work time with rubbish which likely were contaminated with rodents’ feces and urine. Several studies have discussed the role of indirect (aerosols) and direct (physical contacts) transmission modes in hantavirus dynamics. Since the amount of saliva secreted into the environment is not very considerable, direct contacts are needed for an efficient transmission via saliva. In contrast, shedding of the virus in urine and feces would escalate the probability of indirect transmission, since the amounts of secreted urine and feces exceed that of saliva. As a result, indirect transmission makes the transmission rate less dependent on the rodent density and enhances the persistence of virus in the rodent population. Also, some studies emphasize the significance of hantavirus survival outside the rodent host for transmission dynamics and human risk [<xref ref-type="bibr" rid="scirp.51359-ref8">8</xref>] . Given gender prevalence of hantavirus infection among population in this study, all collected cases in our study were men, because sweeping is being performed almost exclusively by men in Iran.</p></sec><sec id="s5"><title>4B5. Conclusion</title><p>There is no previous published data on hantavirus infection in Iran and laboratory diagnoses or clinical cases are not much known in Iran. Thus, general physicians are probably unaware about the aetiology of hantavirus. This proposes that there could be circulation of the hantaviruses in the Iranian population. A major objective of our study was to raise the public awareness for the hantavirus infections as a public health threat and to include hantavirus in surveillance studies in Iran. In future studies, priority should also be given to Sero-epidemiologic studies in human and rodent population in different geographical region of Iran in order to define the true prevalence and risk factors for acquiring hantavirus infection.</p></sec><sec id="s6"><title>5BConflict of Interest</title><p>We declare no conflict of interest.</p></sec><sec id="s7"><title>6BAcknowledgements</title><p>We thank all of the members of the Arboviruses and Viral Hemorrhagic Fevers Laboratory (National Reference Laboratory), Pasteur Institute of Iran.</p></sec><sec id="s8"><title>7BReferences</title><p>[<xref ref-type="bibr" rid="scirp.51359-ref1">1</xref>] Peters, C. and Khan, A.S. (2002) Hantavirus Pulmonary Syndrome: The New American Hemorrhagic Fever. Clinical Infectious Diseases, 34, 1224-1231. http://dx.doi.org/10.1086/339864</p><p>[<xref ref-type="bibr" rid="scirp.51359-ref2">2</xref>] Schmaljohn, C. and Hjelle, B. (1997) Hantaviruses: A Global Disease Problem. Emerging Infectious Diseases, 3, 95- 104. http://dx.doi.org/10.3201/eid0302.970202</p><p>[<xref ref-type="bibr" rid="scirp.51359-ref3">3</xref>] Clement, J.P. (2003) Hantavirus. Antiviral Research, 57, 121-127. http://dx.doi.org/10.1016/S0166-3542(02)00205-X</p><p>[<xref ref-type="bibr" rid="scirp.51359-ref4">4</xref>] Sarıg&#252;zel, N., Hofmann, J., Canpolat, A.T., et al. (2012) Dobrava Hantavirus Infection Complicated by Panhypopituitarism, Istanbul, Turkey, 2010. Emerging Infectious Diseases, 18, 1180-1183. http://dx.doi.org/10.3201/eid1807.111746</p><p>[<xref ref-type="bibr" rid="scirp.51359-ref5">5</xref>] Jonsson, C.B., Figueiredo, L.T.M. and Vapalahti, O. (2010) A Global Perspective on Hantavirus Ecology, Epidemiology, and Disease. Clinical Microbiology Reviews, 23, 412-441. http://dx.doi.org/10.1128/CMR.00062-09</p><p>[<xref ref-type="bibr" rid="scirp.51359-ref6">6</xref>] Frey, M.T., Vial, P.C., Castillo, C.H., et al. (2003) Hantavirus Prevalence in the IX Region of Chile. Emerging Infectious Diseases, 9, 827-832. http://dx.doi.org/10.3201/eid0907.020587</p><p>[<xref ref-type="bibr" rid="scirp.51359-ref7">7</xref>] Jay, M., Ascher, M.S., Chomel, B.B., et al. (1997) Seroepidemiologic Studies of Hantavirus Infection among Wild Rodents in California. Emerging Infectious Diseases, 3, 183-190. http://dx.doi.org/10.3201/eid0302.970213</p><p>[<xref ref-type="bibr" rid="scirp.51359-ref8">8</xref>] Kallio, E.R., Klingstr&#246;m, J., Gustafsson, E., et al. (2006) Prolonged Survival of Puumala Hantavirus Outside the Host: Evidence for Indirect Transmission via the Environment. Journal of General Virology, 87, 2127-2134. http://dx.doi.org/10.1099/vir.0.81643-0</p><p>[<xref ref-type="bibr" rid="scirp.51359-ref9">9</xref>] Chinikar, S., Shayesteh, M., Khakifirouz, S., et al. (2013) Nosocomial Infection of Crimean-Congo Haemorrhagic Fever in Eastern Iran: Case Report. Travel Medicine and Infectious Disease, 11, 252-255. http://dx.doi.org/10.1016/j.tmaid.2012.11.009</p><p>[<xref ref-type="bibr" rid="scirp.51359-ref10">10</xref>] Chinikar, S., Shah-Hosseini, N., Bouzari, S., et al. (2013) New Circulating Genomic Variant of Crimean-Congo Hemorrhagic Fever Virus in Iran, Archives of Virology, 158, 1085-1088. http://dx.doi.org/10.1007/s00705-012-1588-0</p><p>[<xref ref-type="bibr" rid="scirp.51359-ref11">11</xref>] Chinikar, S., Ghiasi, S. M., Shah-Hosseini, N., et al. (2013) Preliminary Study of Dengue Virus Infection in Iran. Travel Medicine and Infectious Disease, 11, 166-169. http://dx.doi.org/10.1016/j.tmaid.2012.10.001</p><p>[<xref ref-type="bibr" rid="scirp.51359-ref12">12</xref>] Chinikar, S., Shah-Hosseini, N., Mostafavi, E., et al. (2013) Seroprevalence of West Nile Virus in Iran. Vector-Borne and Zoonotic Diseases, 13, 586-589. http://dx.doi.org/10.1089/vbz.2012.1207</p><p>[<xref ref-type="bibr" rid="scirp.51359-ref13">13</xref>] Chinikar, S., Shah-Hosseini, N., Mostafavi, E., Jalali, T. and Fooks, A.R. (2013) Surveillance of Rift Valley Fever in Iran between 2001 and 2011. All Results Journals, 4, 16-18.</p><p>[<xref ref-type="bibr" rid="scirp.51359-ref14">14</xref>] Rovida, F., Percivalle, E., Sarasini, A., Chichino, G. and Baldanti, F. (2013) Imported Hantavirus Cardiopulmonary Syndrome in an Italian Traveller Returning from Cuba. The New Microbiologica, 36, 103-105.</p><p>[<xref ref-type="bibr" rid="scirp.51359-ref15">15</xref>] Oncul, O., Atalay, Y., Onem, Y., et al. (2011) Hantavirus Infection in Istanbul, Turkey. Emerging Infectious Diseases, 17, 303-304. http://dx.doi.org/10.3201/eid1702.100663</p><p>[<xref ref-type="bibr" rid="scirp.51359-ref16">16</xref>] Escadafal, C., Avšič-Županc, T., Vapalahti, O., et al. (2012) Second External Quality Assurance Study for the Serological Diagnosis of Hantaviruses in Europe. PLoS Neglected Tropical Diseases, 6, e1607.</p><p>[<xref ref-type="bibr" rid="scirp.51359-ref17">17</xref>] Hofmann, J., Meisel, H., Klempa, B., et al. (2008) Hantavirus Outbreak, Germany, 2007. Emerging Infectious Diseases, 14, 850-852. http://dx.doi.org/10.3201/eid1405.071533</p><p>[<xref ref-type="bibr" rid="scirp.51359-ref18">18</xref>] Heyman, P., Cochez, C., Korukluoğlu, G., et al. (2011) Bridging Continents: Hantaviruses of Europe and Asia Minor. T&#252;rk Hijyen ve Deneysel Biyoloji Dergisi, 68, 41-48. http://dx.doi.org/10.5505/TurkHijyen.2011.33254</p><p>[<xref ref-type="bibr" rid="scirp.51359-ref19">19</xref>] Gozalan, A., Kalaycioglu, H., Uyar, Y., et al. (2013) Human Puumala and Dobrava Hantavirus Infections in the Black Sea Region of Turkey: A Cross-Sectional Study. Vector-Borne and Zoonotic Diseases, 13, 111-118. http://dx.doi.org/10.1089/vbz.2011.0939</p></sec><sec id="s9"><title>NOTES</title></sec></body><back><ref-list><title>References</title><ref id="scirp.51359-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Peters, C. and Khan, A.S. (2002) Hantavirus Pulmonary Syndrome: The New American Hemorrhagic Fever. Clinical Infectious Diseases, 34, 1224-1231. http://dx.doi.org/10.1086/339864</mixed-citation></ref><ref id="scirp.51359-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Schmaljohn, C. and Hjelle, B. (1997) Hantaviruses: A Global Disease Problem. Emerging Infectious Diseases, 3, 95-104. http://dx.doi.org/10.3201/eid0302.970202</mixed-citation></ref><ref id="scirp.51359-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Clement, J.P. (2003) Hantavirus. Antiviral Research, 57, 121-127. http://dx.doi.org/10.1016/S0166-3542(02)00205-X</mixed-citation></ref><ref id="scirp.51359-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Sarigüzel, N., Hofmann, J., Canpolat, A.T., et al. (2012) Dobrava Hantavirus Infection Complicated by Panhypopituitarism, Istanbul, Turkey, 2010. Emerging Infectious Diseases, 18, 1180-1183. http://dx.doi.org/10.3201/eid1807.111746</mixed-citation></ref><ref id="scirp.51359-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Jonsson, C.B., Figueiredo, L.T.M. and Vapalahti, O. (2010) A Global Perspective on Hantavirus Ecology, Epidemiology, and Disease. Clinical Microbiology Reviews, 23, 412-441. http://dx.doi.org/10.1128/CMR.00062-09</mixed-citation></ref><ref id="scirp.51359-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Frey, M.T., Vial, P.C., Castillo, C.H., et al. (2003) Hantavirus Prevalence in the IX Region of Chile. Emerging Infectious Diseases, 9, 827-832. http://dx.doi.org/10.3201/eid0907.020587</mixed-citation></ref><ref id="scirp.51359-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Jay, M., Ascher, M.S., Chomel, B.B., et al. (1997) Seroepidemiologic Studies of Hantavirus Infection among Wild Rodents in California. Emerging Infectious Diseases, 3, 183-190. http://dx.doi.org/10.3201/eid0302.970213</mixed-citation></ref><ref id="scirp.51359-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Kallio, E.R., Klingstr&amp;ouml;m, J., Gustafsson, E., et al. (2006) Prolonged Survival of Puumala Hantavirus Outside the Host: Evidence for Indirect Transmission via the Environment. Journal of General Virology, 87, 2127-2134. http://dx.doi.org/10.1099/vir.0.81643-0</mixed-citation></ref><ref id="scirp.51359-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Chinikar, S., Shayesteh, M., Khakifirouz, S., et al. (2013) Nosocomial Infection of Crimean-Congo Haemorrhagic Fever in Eastern Iran: Case Report. Travel Medicine and Infectious Disease, 11, 252-255. http://dx.doi.org/10.1016/j.tmaid.2012.11.009</mixed-citation></ref><ref id="scirp.51359-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Chinikar, S., Shah-Hosseini, N., Bouzari, S., et al. (2013) New Circulating Genomic Variant of Crimean-Congo Hemorrhagic Fever Virus in Iran, Archives of Virology, 158, 1085-1088. http://dx.doi.org/10.1007/s00705-012-1588-0</mixed-citation></ref><ref id="scirp.51359-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Chinikar, S., Ghiasi, S. M., Shah-Hosseini, N., et al. (2013) Preliminary Study of Dengue Virus Infection in Iran. Travel Medicine and Infectious Disease, 11, 166-169. http://dx.doi.org/10.1016/j.tmaid.2012.10.001</mixed-citation></ref><ref id="scirp.51359-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Chinikar, S., Shah-Hosseini, N., Mostafavi, E., et al. (2013) Seroprevalence of West Nile Virus in Iran. Vector-Borne and Zoonotic Diseases, 13, 586-589. http://dx.doi.org/10.1089/vbz.2012.1207</mixed-citation></ref><ref id="scirp.51359-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Chinikar, S., Shah-Hosseini, N., Mostafavi, E., Jalali, T. and Fooks, A.R. (2013) Surveillance of Rift Valley Fever in Iran between 2001 and 2011. All Results Journals, 4, 16-18.</mixed-citation></ref><ref id="scirp.51359-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Rovida, F., Percivalle, E., Sarasini, A., Chichino, G. and Baldanti, F. (2013) Imported Hantavirus Cardiopulmonary Syndrome in an Italian Traveller Returning from Cuba. The New Microbiologica, 36, 103-105.</mixed-citation></ref><ref id="scirp.51359-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Oncul, O., Atalay, Y., Onem, Y., et al. (2011) Hantavirus Infection in Istanbul, Turkey. Emerging Infectious Diseases, 17, 303-304. http://dx.doi.org/10.3201/eid1702.100663</mixed-citation></ref><ref id="scirp.51359-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Escadafal, C., Avsic-Zupanc, T., Vapalahti, O., et al. (2012) Second External Quality Assurance Study for the Serological Diagnosis of Hantaviruses in Europe. PLoS Neglected Tropical Diseases, 6, e1607.</mixed-citation></ref><ref id="scirp.51359-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Hofmann, J., Meisel, H., Klempa, B., et al. (2008) Hantavirus Outbreak, Germany, 2007. Emerging Infectious Diseases, 14, 850-852. http://dx.doi.org/10.3201/eid1405.071533</mixed-citation></ref><ref id="scirp.51359-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Heyman, P., Cochez, C., Korukluoglu, G., et al. (2011) Bridging Continents: Hantaviruses of Europe and Asia Minor. Türk Hijyen ve Deneysel Biyoloji Dergisi, 68, 41-48. http://dx.doi.org/10.5505/TurkHijyen.2011.33254</mixed-citation></ref><ref id="scirp.51359-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Gozalan, A., Kalaycioglu, H., Uyar, Y., et al. (2013) Human Puumala and Dobrava Hantavirus Infections in the Black Sea Region of Turkey: A Cross-Sectional Study. Vector-Borne and Zoonotic Diseases, 13, 111-118. http://dx.doi.org/10.1089/vbz.2011.0939</mixed-citation></ref></ref-list></back></article>